Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Danan Gan"'
Autor:
Peng Zhang, Danan Gan, Xiaoling Chi, Dewen Mao, Yueqiu Gao, Yong Li, Daqiao Zhou, Qin Li, Mingxiang Zhang, Bingjiu Lu, Fengyi Li, Jingdong Xue, Xianbo Wang, Hongbo Du, Xiaoke Li, Yijun Liang, Yongan Ye
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Number connection test A (NCT-A) and digit symbol test (DST), the preferential neuropsychological tests to detect minimal hepatic encephalopathy (MHE) in China, haven’t been standardized in Chinese population. We aimed to establish the nor
Externí odkaz:
https://doaj.org/article/8d036900e54144e181cce79155b35c74
Autor:
Xiaoke Li, Ludan Zhang, Mei Qiu, Yi Huang, Huanming Xiao, Bingjiu Lu, Yuyong Jiang, Fuli Long, Hui Lin, Jinyu He, Qikai Wu, Mingxiang Zhang, Li Wang, Xiaoning Zhu, Man Gong, Xuehua Sun, Jianguang Sun, Fengxia Sun, Wei Lu, Weihua Xu, Guang Chen, Zhiguo Li, Danan Gan, Xianzhao Yang, Hongbo Du, Yong’an Ye
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background Nucleos(t)ide analogues (NAs) are the first-line option against chronic hepatitis B (CHB). NAs produce potent suppression of viral replication with a small chance of HBsAg seroclearance and a high risk of virological relapse after
Externí odkaz:
https://doaj.org/article/4877a011b28341079a065ce27e05da54
Autor:
Zhiguo Li, Hongbo Du, Xianzhao Yang, Jian-Chun Guo, Mingxiang Zhang, Xianbo Wang, Qikai Wu, Li-Yun He, Yongan Ye, Hui Guo, Xiaoke Li, Danan Gan, Li Yong, Bing-Jiu Lu, Xin-Wei Zhang, Li Wang, Zhou Daqiao, Feng Jiang, Lin Luo, Wei Lu, Xiao-Ling Chi, Ludan Zhang, Qin Li, Jing-Dong Xue, Dewen Mao
Publikováno v:
Hepatology international. 14(6)
Traditional Chinese medicine (TCM) is widely accepted and prescribed in China alongside Nucleoside analogs (NAs). In this double-blind, placebo-controlled, randomized, multi-center trial, we evaluated whether entecavir (ETV) plus TCM formulas Tiao-Ga
Autor:
Jinyu He, Xianzhao Yang, Bing-Jiu Lu, Guang Chen, Yi Huang, Weihua Xu, Man Gong, Mei Qiu, Ludan Zhang, Xiaoke Li, Mingxiang Zhang, Huanming Xiao, Qikai Wu, Jianguang Sun, Fuli Long, Fengxia Sun, Yuyong Jiang, Hui Lin, Li Wang, Danan Gan, Yongan Ye, Wei Lu, Hongbo Du, Xiaoning Zhu, Xuehua Sun, Zhiguo Li
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-9 (2020)
Trials
Trials
BackgroundNucleos(t)ide analogues (NAs) are the first-line option against chronic hepatitis B (CHB). NAs produce potent suppression of viral replication with a small chance of HBsAg seroclearance and a high risk of virological relapse after discontin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5577d16d82aa7cc4b7df70a289f3fb
https://doi.org/10.21203/rs.2.19291/v2
https://doi.org/10.21203/rs.2.19291/v2
Autor:
Hongbo Du, Xu Cao, Guang Chen, Peng Zhang, Xiaoke Li, Danan Gan, Zhiguo Li, Jiaying Zhang, Jiaxin Zhang, Yongan Ye, Ludan Zhang
Publikováno v:
Journal of Cancer
It is the great priority to detect colorectal cancer (CRC) as early as possible, finally to reduce the incidence and mortality of CRC. However, although colonoscopy is recommended in many consensuses, yet no one systematic review is conducted to figu
Autor:
Hongbo Du, Yongan Ye, Jiaying Zhang, Peng Zhang, Danan Gan, Xu Cao, Jiaxin Zhang, Xiaoke Li, Guang Chen, Mei Han
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 2, p e0228857 (2020)
PLoS ONE, Vol 15, Iss 2, p e0228857 (2020)
Objective Hepatocellular carcinoma (HCC) has become a pressing health problem facing the world today due to its high morbidity, high mortality, and late discovery. As a diagnostic criteria of HCC, the exact threshold of Alpha-fetoprotein (AFP) is con
Autor:
Xiaoke Li, Yong'an Ye, Hongbo Du, Ludan Zhang, Mei Qiu, Yi Huang, Huanming Xiao, Bingjiu Lu, Yuyong Jiang, Fuli Long, Hui Lin, Jinyu He, Qikai Wu, Mingxiang Zhang, Li Wang, Xiaoning Zhu, Man Gong, Xuehua Sun, Jianguang Sun, Fengxia Sun, Wei Lu, Zhiguo Li, Danan Gan, Xianzhao Yang
Background: Nucleos(t)ide analogs (NAs) are the first-line options against chronic hepatitis B (CHB). NAs produce a potent suppression of viral replication but are associated with tiny opportunity of HBsAg seroclearance and high risks of virological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81002a9e24a2f9d7b863a9c973cd2feb
https://doi.org/10.21203/rs.2.19291/v1
https://doi.org/10.21203/rs.2.19291/v1
Autor:
Tie-jun Liu, Zhiguo Li, Jian-Dong Zou, Yi-ming Zhao, Wen-Xia Zhao, Hua-Sheng Yang, Peng Zhang, Xianzhao Yang, Jun Li, Xiaoke Li, Qin Li, Jing-Dong Xue, Dewen Mao, Zhou Daqiao, Ke-Ke Zhang, Xiao-Ling Chi, Feng-Zhen Shao, Danan Gan, Bing-Jiu Lu, Hongzhi Yang, Xianbo Wang, Ying Li, Yongan Ye, Meng-Yang Liu, Yong Li, Mingxiang Zhang, Guo-liang Zhang, Shuo Li
Publikováno v:
Chinese journal of integrative medicine. 26(5)
To evaluate the effects of a 48-week course of adefovir dipivoxil (ADV) plus Chinese medicine (CM) therapy, namely Tiaogan Jianpi Hexue (调肝健脾和血) and Tiaogan Jiedu Huashi (调肝解毒化湿) fomulae, in hepatitis B e antigen (HBeAg)-posit
Autor:
Ludan Zhang, YaQiang Zhang, Ying Li, Danan Gan, Peng Zhang, Yijun Liang, Xiaoke Li, Zhiguo Li, Hongbo Du, Yongan Ye, Yuan Cheng
Publikováno v:
Medicine
Background: Minimal hepatic encephalopathy (MHE) is a subclinical state of hepatic encephalopathy with the possibility of developing into overt hepatic encephalopathy (OHE) and having adverse outcomes. However, no preventative medicine for MHE has be
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2017 (2017)
Evidence-Based Complementary and Alternative Medicine, Vol 2017 (2017)
Objective. This aim is to evaluate the effect of Sijunzi decoction (SJZD) treating chronic atrophic gastritis (CAG). Methods. We performed searches in seven databases. The randomized controlled trials (RCTs) comparing SJZD with standard medical care